« Pomalidomide approved for use across Europe Amendments to the pharmacovigilance legislation: new notification requirements… »
Slovak translation of the MPE Report on Myeloma Patient Perspectives is now available Published October 31, 2013 Download your copy here. Recent news» Melflufen receives positive opinion from the European Medicines Agency (EMA) for the treatment of refractory myeloma» EHA 2022 highlights in myeloma and AL amyloidosis Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. I accept the Privacy Policy
Leave a Reply